Quarterly Results

CAPLIN POINT LABORATORIES LTD.

NSE : CAPLIPOINTBSE : 524742ISIN CODE : INE475E01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE1317.3057.35 (+4.55 %)
PREV CLOSE ( ) 1259.95
OPEN PRICE ( ) 1289.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 10903
TODAY'S LOW / HIGH ( )1259.45 1332.55
52 WK LOW / HIGH ( )575 1617.8
NSE1315.3552.25 (+4.14 %)
PREV CLOSE( ) 1263.10
OPEN PRICE ( ) 1274.00
BID PRICE (QTY) 1315.35 (42)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 276479
TODAY'S LOW / HIGH( ) 1257.15 1329.95
52 WK LOW / HIGH ( )575 1619.05
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
Audited
UnAudited
UnAudited
Audited
Net Sales
4355
4100.6
3953.2
3892.8
Total Expenditure
2932.2
2726.6
2687.9
2653.5
PBIDT (Excl OI)
1422.8
1374
1265.3
1239.3
Other Income
171.8
204.3
120.4
114
Operating Profit
1594.6
1578.3
1385.7
1353.3
Interest
1.7
1.8
2.8
2.3
Exceptional Items
NA
NA
NA
NA
PBDT
1592.9
1576.5
1382.9
1351
Depreciation
139
117.6
113.8
111.3
Profit Before Tax
1453.9
1458.9
1269.1
1239.7
Tax
255.9
298.6
227.6
228.1
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
1198
1160.3
1041.5
1011.6
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
1198
1160.3
1041.5
1011.6
Minority Interest
-26.2
-12.7
-8
8.7
Shares of Associates
0.2
1.1
0.8
0.8
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
1172
1148.7
1034.3
1021.1
Equity Capital
151.9
151.9
151.9
151.8
Face Value (IN RS)
2
2
2
2
Reserves
NA
NA
NA
NA
Calculated EPS
15.43
15.12
13.61
13.45
Calculated EPS (Annualised)
61.72
60.49
54.47
53.81
No of Public Share Holdings
22308764
22306764
22300764
22269764
% of Public Share Holdings
29.38
29.37
29.37
29.34
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
32.67
33.50
32.00
31.83
PBIDTM%
36.61
38.48
35.05
34.76
PBDTM%
36.57
38.44
34.98
34.70
PBTM%
33.38
35.57
32.10
31.84
PATM%
27.50
28.29
26.34
25.98
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.